AI assistant
INTUITIVE SURGICAL INC — Director's Dealing 2023
Aug 1, 2023
29809_dirs_2023-08-01_90a7898c-8f1c-486b-94d3-b44814dca739.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2023-07-28
Reporting Person: GUTHART GARY S (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-07-28 | Common Stock | M | 67500 | $42.6367 | Acquired | 67500 | Direct |
| 2023-07-28 | Common Stock | S | 50314 | $326.7626 | Disposed | 17186 | Direct |
| 2023-07-28 | Common Stock | G | 16000 | $0.0 | Disposed | 1180093 | Indirect |
| 2023-07-31 | Common Stock | S | 2480 | $325.89 | Disposed | 32320 | Indirect |
| 2023-07-31 | Common Stock | S | 2480 | $325.89 | Disposed | 32320 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-07-28 | Non-Qualified Stock Option (right to buy) | $42.6367 | M | 67500 | Disposed | 2023-08-15 | Common Stock (67500) | Direct |
Footnotes
F1: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2024.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $325.13 to $328.45 as follows: 8,061 shares sold at $325.13 to $326.10; 26,670 shares sold at $326.14 to $327.12; 14,483 shares sold at $327.15 to $327.95; and 1,100 shares sold at $328.34 to $328.45. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3: The shares were donated to a Donor Advised Fund (DAF) in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2024.
F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.